Recent Quotes
You have no recent quotes
Benzinga - Fri, 05 Mar 2021 12:53:16 -0400
Benzinga - Wed, 27 Jan 2021 06:10:49 -0400
Benzinga - Fri, 18 Dec 2020 15:41:54 -0400
Benzinga - Fri, 18 Dec 2020 08:45:00 -0400
Benzinga - Tue, 15 Dec 2020 08:52:33 -0400
Benzinga - Wed, 09 Dec 2020 08:23:02 -0400
Benzinga - Tue, 08 Dec 2020 09:03:54 -0400
Benzinga - Fri, 04 Dec 2020 09:07:07 -0400
Benzinga - Fri, 04 Dec 2020 06:08:07 -0400
Benzinga - Wed, 02 Dec 2020 08:35:27 -0400
Benzinga - Tue, 01 Dec 2020 09:08:03 -0400
Benzinga - Thu, 19 Nov 2020 09:21:49 -0400
Benzinga - Wed, 18 Nov 2020 17:40:06 -0400
Benzinga - Tue, 17 Nov 2020 10:55:20 -0400
Benzinga - Tue, 17 Nov 2020 10:12:26 -0400
load more
Foghorn Therapeutics Inc is engaged in discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Its proprietary Gene Traffic Control platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-06-04 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-03-19 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Price | Change | Chg % | Mkt Cap | |
|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics | 13.71 | -0.98 | -6.67% | 504.1M |
Foghorn Therapeutics Company Questions & Answers
Q
How do I buy Foghorn Therapeutics (FHTX) stock?
A
You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.
Q
Who are Foghorn Therapeutics's (FHTX) main competitors?
A
There are no as such competitors for Foghorn Therapeutics.
Q
What is the target price for Foghorn Therapeutics?
A
The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Wedbush on 2020-11-17. The analyst firm set a price target for 24.00 expecting FHTX to rise to within 12 months (a possible 75.05% upside). 4 analyst firms have reported ratings in the last year.
Q
How much is Foghorn Therapeutics (FHTX) stock ?
A
The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $13.71 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Foghorn Therapeutics (FHTX) dividend?
A
There are no upcoming dividends for Foghorn Therapeutics.
Q
When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?
A
Foghorn Therapeutics’s Q1 earnings are confirmed from now on June 4, 2021.
Q
When is the upcoming split for FHTX?
A
There is no upcoming split for Foghorn Therapeutics.